The zoonotic pathogen Wohlfahrtiimonas chitiniclastica – current findings from a clinical and genomic perspective

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • Anna Kopf - , Sana Heart Center Cottbus (Author)
  • Boyke Bunk - , German Collection of Microorganisms and Cell Cultures (Author)
  • Thomas Riedel - , German Collection of Microorganisms and Cell Cultures (Author)
  • Percy Schröttner - , Institute of Clinical Chemistry and Laboratory Medicine (Author)

Abstract

The zoonotic pathogen Wohlfahrtiimonas chitiniclastica can cause several diseases in humans, including sepsis and bacteremia. Although the pathogenesis is not fully understood, the bacterium is thought to enter traumatic skin lesions via fly larvae, resulting in severe myiasis and/or wound contamination. Infections are typically associated with, but not limited to, infestation of an open wound by fly larvae, poor sanitary conditions, cardiovascular disease, substance abuse, and osteomyelitis. W. chitiniclastica is generally sensitive to a broad spectrum of antibiotics with the exception of fosfomycin. However, increasing drug resistance has been observed and its development should be monitored with caution. In this review, we summarize the currently available knowledge and evaluate it from both a clinical and a genomic perspective.

Details

Original languageEnglish
Article number3
Pages (from-to)3
JournalBMC Microbiology
Volume24
Issue number1
Publication statusPublished - 3 Jan 2024
Peer-reviewedYes

External IDs

PubMed 38172653
Scopus 85181233189

Keywords

Sustainable Development Goals

Keywords

  • Animals, Gammaproteobacteria/genetics, Larva, Humans, Genomics, Diptera/microbiology, Anti-Bacterial Agents/pharmacology